Magdalena Wolska , MSc
Magdalena Wolska is a PhD student at the renowned Nencki Institute of Experimental Biology, where she conducts advanced research on metabolites derived from the intestinal microbiota and their impact on the immune system. As part of her research, Magdalena participates in national and international projects aimed at developing innovative therapeutic strategies in the treatment of acute respiratory distress syndrome. Her work is extremely important in the context of searching for new treatments that can improve the quality of life of patients. Magdalena is the author and co-author of numerous scientific publications, including articles on the impact of premature birth on the development of lung diseases and the interactions between microbiota metabolites and the immune system. Her commitment to research and the ability to effectively communicate results at scientific conferences make her recognized as a valuable member of her academic community.
Prizes and awards:
Award for the short talk entitled “Microbiota-derived metabolite improves lung inflammation by modulating the metabolism of alveolar macrophages” at the 8th International PhD Conference, Nencki Institute, Warsaw (Poland)
Selected publications:
- Wolska, M., Wypych, T.P. and Rodríguez-Viso, P. (2024), The Influence of Premature Birth on the Development of Pulmonary Diseases: Focus on the Microbiome. Metabolites,
https://doi.org/10.3390/metabo14070382 - Losol, P., Wolska, M., Wypych, T.P., Yao, L., O'Mahony, L. and Sokolowska, M. (2024), A cross talk between microbial metabolites and host immunity: Its relevance for allergic diseases. Clinical and Translational Allergy,
https://doi.org/10.1002/clt2.12339 - Radke, K., Hansson, K., Sjölund, J., Wolska, M., Karlsson, J., Esfandyari, J., Pietras, K., Aaltonen, K., Gisselsson, D. and Bexell, D. (2021), Anti-tumor effects of rigosertib in high-risk neuroblastoma. Translational Oncology,
https://doi.org/10.1016/j.tranon.2021.101149
